Mutations in the androgen receptor (AR) gene in coding regions have been identified in less than 25% of patients with a clinical diagnosis of PAIS, and such AR mutations remain undetected in a proportion of patients with impaired endogenous AR activity [2]. This evidence concerns the gene AR and partial androgen insensitivity syndrome.